ASBP
Aspire Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ASBP Filings
Filing Date
Form Description
Form Type
2025-12-03
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-12-03 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-11-14
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Financials
2025-11-14 · Financials
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
2025-11-05
Form 8-K - Current report
Key Events
2025-11-05 · Key Events
Form 8-K - Current report
2025-10-17
Form 8-K - Current report
Key Events
2025-10-17 · Key Events
Form 8-K - Current report
2025-09-30
Form EFFECT - Notice of Effectiveness
2025-09-30 ·
Form EFFECT - Notice of Effectiveness
2025-09-26
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025-09-26 ·
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025-09-26
Form 8-K - Current report
Key Events
2025-09-26 · Key Events
Form 8-K - Current report
2025-09-23
Form DEF 14A - Other definitive proxy statements
Key Events
2025-09-23 · Key Events
Form DEF 14A - Other definitive proxy statements
